| Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes CM Connell, S Raby, I Beh, TR Flint, EH Williams, DT Fearon, DI Jodrell, ... Annals of Oncology 28 (7), 1678-1679, 2017 | 31 | 2017 |
| Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with … CM Connell, R Brais, H Whitaker, S Upponi, I Beh, J Risdall, P Corrie, ... BMC cancer 20, 1-6, 2020 | 7 | 2020 |
| Multicenter validation of the CamGFR model for estimated glomerular filtration rate EH Williams, CM Connell, JMJ Weaver, I Beh, H Potts, CT Whitley, N Bird, ... JNCI Cancer Spectrum 3 (4), pkz068, 2019 | 7 | 2019 |
| Knockdown of zif268 in the posterior dorsolateral striatum does not enduringly disrupt a response memory of a rewarded T-maze task EN Cahill, GH Vousden, MTJ Exton-McGuinness, IRC Beh, CB Swerner, ... Neuroscience 370, 112-120, 2018 | 5 | 2018 |
| Cancer immunotherapy trials underutilize immune response monitoring CM Connell, SEM Raby, I Beh, TR Flint, EH Williams, DT Fearon, ... The Oncologist 23 (1), 116-117, 2018 | 4 | 2018 |
| CASE REPORT Open Access CM Connell, R Brais, H Whitaker, S Upponi, I Beh, J Risdall, P Corrie, ... | | 2020 |
| Validation of a new model for estimating glomerular filtration rate in patients with cancer. E Williams, RS Geisler, I Beh, G Bertelli, R Cathomas, MJ Dooley, HM Earl, ... Journal of Clinical Oncology 36 (15_suppl), 2565-2565, 2018 | | 2018 |
